Clostridium perfringens str. 13 (cper0)
Gene : CPE1487
DDBJ :CPE1487 conserved hypothetical protein
Swiss-Prot:
Homologs Archaea 0/68 : Bacteria 83/915 : Eukaryota 0/199 : Viruses 0/175 --->[See Alignment]
c.94.1












:334 amino acids






















































:SECSTR




















































:PSIPRED



:DISOPRED


:BLT:PDB 39->324 3hn0B PDBj 2e-22 30.7 %


:RPS:PDB 39->273 1dtzA PDBj 2e-14 9.6 %


:RPS:SCOP 72->331 2nxoA1 c.94.1.1 * 1e-20 17.3 %


:HMM:SCOP 37->270 1xs5A_ c.94.1.1 * 6.6e-25 25.2 %


:RPS:PFM 74->275 PF02621 * DUF178 2e-13 31.4 %


:HMM:PFM 66->269 PF09084 * NMT1 6e-14 24.4 193/216

:HMM:PFM 1->26 PF08085 * Entericidin 0.0005 50.0 22/42


:HMM:PFM 238->312 PF01540 * Lipoprotein_7 0.001 21.3 75/353


:BLT:SWISS 66->291 YTLA_BACSU 9e-12 25.8 %


:TM




:SEG
SeqInfo AminoSeq See neighboring genes
Links GIB DAD Abbreviations Back to title page
GT:ID BAB81193.1
GT:GENE CPE1487
GT:PRODUCT conserved hypothetical protein
GT:DATABASE GIB00075CH01
GT:ORG cper0
GB:ACCESSION GIB00075CH01
GB:LOCATION complement(1741419..1742423)
GB:FROM 1741419
GB:TO 1742423
GB:DIRECTION -
GB:GENE CPE1487
GB:PRODUCT conserved hypothetical protein
GB:NOTE 334 aa, similar to pir:D72405 hypothetical protein from Thermotoga maritima (strain MSB8) (300 aa); 29.7% identity in 266 aa overlap
GB:PROTEIN_ID BAB81193.1
LENGTH 334
SQ:AASEQ MKKLNKFLSLVLMVLFSLSILVGCNTSKKEEAKAPEEKTSIEIVVPDGLPAISIVKMIKEKPEIMKGLDINYSIVKGSDALVSKVLKGEGDICIVPSNVAAIAYNKEAKYKLAGTVGFGSLYVISSDDSVNSLEDLKGKDVYNVGQGLTPDLIFKILLQNDGINPEKDLTLSYVNAASELAPLFIEGKAKYAVVPEPMLTQIMTKKPETKIVASLNEQWKEMSDSKMGYPQSSVIVKEDLAKNNSEAVQKILKEIDNSTKWANENKEEAGAFAEEVGITGKKEIIAKSLERANLNYVSALDSESEYIKYYDKIYSLEPKAIGGKKVNEEIFLQK
GT:EXON 1|1-334:0|
BL:SWS:NREP 1
BL:SWS:REP 66->291|YTLA_BACSU|9e-12|25.8|217/334|
TM:NTM 1
TM:REGION 4->24|
SEG 8->22|lslvlmvlfslsilv|
SEG 28->38|kkeeakapeek|
BL:PDB:NREP 1
BL:PDB:REP 39->324|3hn0B|2e-22|30.7|264/277|
RP:PDB:NREP 1
RP:PDB:REP 39->273|1dtzA|2e-14|9.6|219/689|
RP:PFM:NREP 1
RP:PFM:REP 74->275|PF02621|2e-13|31.4|185/253|DUF178|
HM:PFM:NREP 3
HM:PFM:REP 66->269|PF09084|6e-14|24.4|193/216|NMT1|
HM:PFM:REP 1->26|PF08085|0.0005|50.0|22/42|Entericidin|
HM:PFM:REP 238->312|PF01540|0.001|21.3|75/353|Lipoprotein_7|
RP:SCP:NREP 1
RP:SCP:REP 72->331|2nxoA1|1e-20|17.3|237/272|c.94.1.1|
HM:SCP:REP 37->270|1xs5A_|6.6e-25|25.2|222/0|c.94.1.1|1/1|Periplasmic binding protein-like II|
OP:NHOMO 98
OP:NHOMOORG 83
OP:PATTERN -------------------------------------------------------------------- -----------------------------------------------------1---1--------------------11-------------1----------------------------------------------------------------------------------------------11---111111--1-111--1--11-111---------------1-------------------------------------------------------------------------------------------21112221222121-111111121---12---22-1-1---1---------------------------21--2-------------------------------------1---2------------------------------------------------------------------------------------------------------1---------------11-----1--1------------1-----------1---------1-1-----------------11-1----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------1--------------1---------------------------1111111111--- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
STR:NPRED 293
STR:RPRED 87.7
SQ:SECSTR ######################################ccEEEEEccHHHHHHHHHHHHHHHTTTccccEEEEEcccHHHHHHHHHTTccccEEEcHHHHHHHHcTTTcEEEEEEEccEEEEEEEEccccccGGGcTTcEEEccTTcTTTTHHHHHHTGGGTccccTTccHHHHHHHGGHHHHHccEEEcTTccTTTcHHHHTTccccGGGTTccTHHHHHHHcTTcTTcHHHHHHHHHHccccHcEEEEETTHHHHHcccHHHHTTEEEEETHHHcTTccHHHHHHHHHHHccHHHHccHHHHcHHHHHHHHHHHHHHHcTTccTTccTT###
DISOP:02AL 1-3, 26-36|
PSIPRED ccHHHHHHHHHHHHHHHHHHHHHcccccccccccccccEEEEEEEEccHHHHHHHHHHHHHHHHHcccEEEEEEcccHHHHHHHHHcccEEEEEEcHHHHHHHHHccccEEEEEEccccEEEEEEcccccccHHHHcccEEEEEccccHHHHHHHHHHHHccccHHHcEEEEEEccHHHHHHHHHHccEEEEEEccHHHHHHHHHcccEEEEEEcHHHHHHHccccccccEEEEEEEHHHHHHcHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHcccccHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHccccccccccccHHHccc
//